No Data
No Data
Sekisui Chemical: Interim Report
SKK Chemicals: Certification Document
SKK Chemicals: Securities Report - 68th Term (April 1, 2023 - March 31, 2024)
Asset Value Investors (AVI) Submits Shareholder Proposals to SK Kaken for the Fourth Year in a Row
Asset Value Investors ("AVI") announces today that it has submitted shareholder proposals to SK Kaken Co., Ltd. (TSE 4628) ("SK Kaken" or the "Company") addressing two issues contributing to the
SoftBank G turns 24/3 ordinary profit and loss surplus to 57.8 billion yen
The financial results for the fiscal year ending 2024/3 announced by SoftBank G were sales of 6.756.5 billion yen, up 2.8% from the previous fiscal year, and ordinary profit and loss surplus of 57.81 billion yen (deficit of 469.27 billion yen in the previous fiscal year). The corporate value of investees improved due to global stock appreciation. The yen equivalent amount of US dollar debt increased due to the depreciation of the yen, and exchange losses of 703.1 billion yen were recorded. The investment profit and loss of the SoftBank Vision Fund (SVF) business was in surplus of 724.3 billion yen. [Positive Evaluation] <2587>Sa
SK Kaken Sees FY Net Y9.50B
SK Kaken Co. Ltd. also released the following forecasts: GROUP 1st Half To Year Ending Sep 2024 Mar 2025 Revenue Y50.00 bln Y103.00 bln Oper
No Data